Anterior Cruciate Ligament (ACL) Revision Surgery: French National Study

This is a national multicentric study led by the French Arthroscopy Society (SFA) evaluating clinical practice in anterior cruciate ligament (ACL) revision surgery (epidemiological data, morphological data, operative data, clinical and functional outcomes, and surgical complication rates).

Study Overview

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Saint-Étienne, France
        • Recruiting
        • CHU Saint-Etienne
        • Principal Investigator:
          • Thomas NERI, MD PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patient with an anterior cruciate ligament (ACL) revision will be included.

Description

Inclusion Criteria:

  • Patient with an anterior cruciate ligament (ACL) revision, defined as "all surgical procedures involving replacement of the anterior cruciate ligament (ACL) graft with a new graft".

Exclusion Criteria:

  • multil-igament injuries
  • any procedure where the ACL was not revised and where any additional graft was inserted
  • Patients who had already undergone their first revision anterior cruciate ligament (ACL) procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patient with Anterior Cruciate Ligament (ACL) revision
Patient with Anterior Cruciate Ligament (ACL) revision will be included. Questionary will be administrated and datas will be collected by medical record.

Questionaries will be administered :

  • Anterior Cruciate Ligament Return to Sport and Injury (ACL-RSI)
  • Tegner Activity Scale (TAS)
  • Simple Knee Value (SKV)
  • International Knee Documentation Commitee (IKDC)
datas of medical record will be collected : epidemiological data, morphological data, operative data, clinical and functional outcomes, and surgical complication.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Results of Functional score questionary Anterior Cruciate Ligament Return to Sport and Injury (ACL-RSI)
Time Frame: Months: 0, 6, 12 and 24

Results of Functional score questionary Anterior Cruciate Ligament Return to Sport and Injury (ACL-RSI) will be analyzed.

questionary Anterior Cruciate Ligament Return to Sport and Injury (ACL-RSI) has 12 questions (min = 0, max = 100). Greater psychological preparation is indicated by higher scores.

Months: 0, 6, 12 and 24
Results of Functional score questionary Tegner Activity Scale (TAS)
Time Frame: Months: 0, 6, 12 and 24

Results of Functional score questionary Tegner Activity Scale (TAS) will be analyzed.

The Tegner Activity Scale (TAS) is a scale of sporting and professional physical activities: from 0 (professional disability due to knee) to 10 (competitive sport such as soccer or rugby at national or international level).

Months: 0, 6, 12 and 24
Results of Functional score questionary Simple Knee Value (SKV)
Time Frame: Months: 0, 6, 12 and 24

Results of Functional score questionary Simple Knee Value (SKV) will be analyzed.

Scale from 0 to 100 to evaluate the knee function in daily life (0 is no function and 100 is normal function)

Months: 0, 6, 12 and 24
Results of Functional score questionary International Knee Documentation Commitee (IKDC)
Time Frame: Months: 0, 6, 12 and 24

Results of Functional score questionary Knee Documentation Commitee (IKDC) will be analyzed.

Subjective evaluation of the knee function (from 0 to 100%, 0 is no function and 100 is normal function)

Months: 0, 6, 12 and 24

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical complications
Time Frame: From surgery to 2 months
Report of surgical complications during the 2 months following the surgery
From surgery to 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Thomas NERI, MD PhD, CHU Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

April 18, 2024

First Submitted That Met QC Criteria

April 22, 2024

First Posted (Actual)

April 23, 2024

Study Record Updates

Last Update Posted (Actual)

July 22, 2024

Last Update Submitted That Met QC Criteria

July 19, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRBN552024/CHUSTE.

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Rupture

Clinical Trials on questionaries

Subscribe